Evidence map›Paper›PMID 36346241›Full record

ArticlemSphere2022

Characterization of MxiE- and H-NS-Dependent Expression of

Chelsea P Hall, Niti B Jadeja, Natalie Sebeck, Hervé Agaisse

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Sequential invasion of epithelial and immune cells in Shigellosis.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Differential targeting of human pyroptotic Caspase-5 and Caspase-4 bybioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Tolfenpyrad displaysMicrobiology spectrum · 2023
    Article
  7. Review
  8. Article
  9. A Tale aboutMicroorganisms · 2023
    Review
  10. VirB, a key transcriptional regulator ofbioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chelsea P HallDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.
Niti B JadejaDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.
Natalie SebeckDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.
Hervé AgaisseDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0002-3350-0218
University of Virginia · US

Funding

Global Biothreats Training ProgramT32AI055432 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CRISS, ALISON K, PETRI, WILLIAM A · 2003 to 2022
$4.0M
NIAID NIH HHS T32 AI055432NIH HHS 5T32AI055432
6 · The paper itself

Abstract

Shigella flexneri uses a type 3 secretion system (T3SS) apparatus to inject virulence effector proteins into the host cell cytosol. Upon host cell contact, MxiE, an S. flexneri AraC-like transcriptional regulator, is required for the expression of a subset of T3SS effector genes encoded on the large virulence plasmid. Here, we defined the MxiE regulon using RNA-seq. We identified virulence plasmid- and chromosome-encoded genes that are activated in response to type 3 secretion in a MxiE-dependent manner. Bioinformatic analysis revealed that similar to previously known MxiE-dependent genes, chromosome-encoded genes

Indexed as

Bacterial ProteinsDNA-Binding ProteinsShigella flexneriTranscription FactorsType III Secretion SystemsBacterial ProteinsDNA-Binding ProteinsTranscription FactorsType III Secretion Systemsanti-silencingH-NSMxiEShigellasilencingT3SS

Identifiers

PMID36346241
PMCPMC9769918
OpenAlexW4308507721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.